Abstract
Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
Nigel L Ashworth, Paul M Peloso, Nazeem Muhajarine and Maryrose Stang
The Journal of Rheumatology November 2005, 32 (11) 2212-2217;
Nigel L Ashworth
Paul M Peloso
Nazeem Muhajarine
In this issue
The Journal of Rheumatology
Vol. 32, Issue 11
1 Nov 2005
Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
Nigel L Ashworth, Paul M Peloso, Nazeem Muhajarine, Maryrose Stang
The Journal of Rheumatology Nov 2005, 32 (11) 2212-2217;
Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
Nigel L Ashworth, Paul M Peloso, Nazeem Muhajarine, Maryrose Stang
The Journal of Rheumatology Nov 2005, 32 (11) 2212-2217;